Concepedia

Narender R. Gavva

NR

50

Publications

4.9K

Citations

35

H-Index

1997

Active since

Affiliations

Amgen (United States)(Current)

St. Joseph's Hospital and Medical Center

University of California, Davis

Institute of Molecular Biology, Academia Sinica

University of Pecs

Narender R. Gavva is an author at Amgen (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1997–2021

50

Publications

50

Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans

Narender R. Gavva, James Treanor, András Garami et al. · Pain · 2008 · 503 citations

, , +15

AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties

Narender R. Gavva, Rami Tamir, Yusheng Qu et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 385 citations

Molecular Determinants of Vanilloid Sensitivity in TRPV1

Narender R. Gavva, Lana Klionsky, Yusheng Qu et al. · Journal of Biological Chemistry · 2004 · 355 citations · Full text

The Vanilloid Receptor TRPV1 Is Tonically Activated <i>In Vivo</i> and Involved in Body Temperature Regulation

Narender R. Gavva, Anthony W. Bannon, Sekhar Surapaneni et al. · Journal of Neuroscience · 2007 · 308 citations · Full text

Pharmacological Blockade of the Cold Receptor TRPM8 Attenuates Autonomic and Behavioral Cold Defenses and Decreases Deep Body Temperature

Maria Camila Almeida, Tamara Hew‐Butler, Renato Nery Soriano et al. · Journal of Neuroscience · 2012 · 257 citations · Full text

, , +19

Rows per page

1–5 of 50